BACKGROUND:Growth differentiation factor-15 (GDF-15), Cystatin C and C-reactive protein (CRP) have been discussed as biomarkers for prediction of cardiac diseases. The aim of this study was to investigate the predictive value of single and repeated measurements of GDF-15 compared to Cystatin C and CRP for incidence of heart failure (HF) and death due to coronary heart disease (CHD) in the general population. METHODS AND RESULTS:Levels of GDF-15, CRP and Cystatin C were determined in three repeated measurements collected 5 years apart in the DAN-MONICA (Danish-Multinational MONitoring of trends and determinants in Cardiovascular disease) cohort (participants at baseline n = 3785). Cox regression models adjusted for cardiovascular risk factor...
The objective was to evaluate the hypothesis that growth-differentiation factor 15 (GDF-15) is an in...
Growth differentiation factor-15 (GDF-15) is produced by cardiomyocytes and atherosclerotic lesions ...
Cardiovascular diseases remain the primary cause of death in developed countries, including Poland, ...
<div><p>Background</p><p>Growth differentiation factor-15 (GDF-15), Cystatin C and C-reactive protei...
Background: Previous studies have proposed growth differentiation factor-15 (GDF-15) as a predictor ...
We explored the prognostic utility of growth differentiation factor (GDF)-15 in patients with chroni...
The aim of this study was to determine whether growth differentiation factor-15 (GDF-15) predicts mo...
Background—Growth-differentiation factor-15 (GDF-15) is a stress-responsive transforming growth fact...
ObjectivesWe explored the prognostic utility of growth differentiation factor (GDF)-15 in patients w...
Among the numerous emerging biomarkers, high-sensitivity C-reactive protein (hsCRP) and growth-diffe...
Background: Previous studies had reported increased circulating concentrations of growth differentia...
Background: Studies on serially measured GDF-15 (growth differentiation factor 15) in acute heart fa...
Aim. To evaluate the prognostic value of growth differentiation factor-15 (GDF-15) in patients with ...
Heart failure (HF) biomarker-guided therapy is a promising method, which directs to the improvement ...
Background: Growth Differentiation Factor-15 (GDF-15) has emerged as a biomarker that capable to pre...
The objective was to evaluate the hypothesis that growth-differentiation factor 15 (GDF-15) is an in...
Growth differentiation factor-15 (GDF-15) is produced by cardiomyocytes and atherosclerotic lesions ...
Cardiovascular diseases remain the primary cause of death in developed countries, including Poland, ...
<div><p>Background</p><p>Growth differentiation factor-15 (GDF-15), Cystatin C and C-reactive protei...
Background: Previous studies have proposed growth differentiation factor-15 (GDF-15) as a predictor ...
We explored the prognostic utility of growth differentiation factor (GDF)-15 in patients with chroni...
The aim of this study was to determine whether growth differentiation factor-15 (GDF-15) predicts mo...
Background—Growth-differentiation factor-15 (GDF-15) is a stress-responsive transforming growth fact...
ObjectivesWe explored the prognostic utility of growth differentiation factor (GDF)-15 in patients w...
Among the numerous emerging biomarkers, high-sensitivity C-reactive protein (hsCRP) and growth-diffe...
Background: Previous studies had reported increased circulating concentrations of growth differentia...
Background: Studies on serially measured GDF-15 (growth differentiation factor 15) in acute heart fa...
Aim. To evaluate the prognostic value of growth differentiation factor-15 (GDF-15) in patients with ...
Heart failure (HF) biomarker-guided therapy is a promising method, which directs to the improvement ...
Background: Growth Differentiation Factor-15 (GDF-15) has emerged as a biomarker that capable to pre...
The objective was to evaluate the hypothesis that growth-differentiation factor 15 (GDF-15) is an in...
Growth differentiation factor-15 (GDF-15) is produced by cardiomyocytes and atherosclerotic lesions ...
Cardiovascular diseases remain the primary cause of death in developed countries, including Poland, ...